News Archive

Lab21 launches breakthrough service for the assessment of liver disease 15 Aug 2005: Lab21 has announced the availability of a new, easily accessible clinical testing service that uses the groundbreaking FibroTest-ActiTest™ system LAB 21

AWARDS RECOGNITION FOR SYFT TECHNOLOGIES 12 Aug 2005: Syft Technologies, known as one of Christchurch’s most innovative companies, was this week announced as a finalist  in the upcoming Champion Canterbury awards. Syft Technologies

Quest Diagnostics' Care360 Physician Portal Connects to Retail Pharmacies Using the SureScripts Electronic Prescribing Network 08 Aug 2005: Connection Enables Two-Way Communication Between Physicians and Pharmacies Quest Diagnostics

BIOHIT Helicobacter pylori IgG ELISA kit FDA cleared for Marketing & Distribution 27 Jul 2005: Biohit Plc has received on 13.12.2004 FDA clearance for the Company's Helicobacter pylori IgG ELISA kit. Test is based on an enzyme immunoassay technique with partially purified H. pylori bacterial antigen adsorbed on a microplate and a detection antibody labeled with horseradish peroxidase (HRP). Biohit

New method of detecting alcohol misuse using CDT test for Sebia Capillarys 12 Jul 2005: Increased Carbohydrate Deficient Transferrin (CDT) is an indication of regular heavy alcohol consumption which can now be detected using capillary electrophoresis on Sebia’s Capillarys available from Analytical Technologies. Analytical Technologies

Eppendorf products conform to IVD Directive 98/79/EC 22 Apr 2005: Eppendorf has ensured that all its products are certified in conformity with IVD Directive 98/79/EC and the associated EN standards. The Directive applies to all clinical laboratories throughout the EU which perform human diagnostics. Eppendorf UK Limited

Eppendorf paves the way for new approaches to breast cancer diagnostics 08 Dec 2004: Breast Cancer Biochips for widespread application in research and clinics Eppendorf UK Limited